Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study

被引:23
|
作者
Zhou, Xingtong [1 ]
Zheng, Zhibo [2 ]
Chen, Chuyan [3 ]
Zhao, Bangbo [4 ]
Cao, Hongtao [4 ]
Li, Tianhao [4 ]
Liu, Xudong [5 ]
Wang, Weibin [4 ]
Li, Yongning [2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Int Med Serv, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, 1 Shuaifuyuan Wangfujing, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Sci Res Ctr, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Thyroid Hurthle cell carcinoma; SEER database; Survival factors; SURVIVAL; RECURRENCE; TUMORS; LEVEL;
D O I
10.1186/s12885-020-06915-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThyroid Hurthle cell carcinoma (HCC) is a rare disease with high risk of invasion and metastasis and poor prognosis. The clinical characteristics, prognosis and treatment of HCC are still controversial, and clinical data are still limited to some case reports. Therefore, understanding the characteristics and survival factors of HCC is clinically necessary.MethodsThis study collected data from HCC patients diagnosed pathologically from 2004 to 2015, including basic population characteristics, tumor characteristics, and epidemiological and survival data. The data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database to conduct a population cohort study.ResultsA total of 2101 HCC patients with an average age of 55.4215.27years were enrolled in this study. Of them, 1740 (82.82%) patients had local disease, 245 (11.66%) had regional disease, and 89 (4.24%) had distant disease. Total thyroidectomy was performed in 1669 (79.44%) patients, partial thyroidectomy was performed in 382 (18.18%) patients, and radioactive iodine (RAI) was used in 1155 (54.97%) patients. The 5-year and 10-year cancer-specific survival rate was 95.4 and 92.6%, respectively. The distant disease group had significantly more male patients, multifocal tumors, and extensive tumors compared to the local disease group. Multivariate survival analysis showed that age (P<0.05), SEER stage (P<0.001), and T-stage (P=0.001) had significant effects on survival. There was no significant difference in survival between total and partial thyroidectomy (P=0.078), or between RAI and non-RAI (P=0.733).Conclusion p id=Par Male gender, multifocal tumors, and extended tumors are associated with increased risk of late stage HCC. Age over 45years, distant SEER stage, and late T-stage are independent risk factors for mortality in HCC.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study
    Xingtong Zhou
    Zhibo Zheng
    Chuyan Chen
    Bangbo Zhao
    Hongtao Cao
    Tianhao Li
    Xudong Liu
    Weibin Wang
    Yongning Li
    BMC Cancer, 20
  • [2] Prognostic factors and survival analysis of Hurthle cell carcinoma: A population-based study
    Humphreys, Bailey M.
    Memeh, Kelvin O.
    Funkhouser, Alex
    Vaghaiwalla, Tanaz M.
    SURGERY, 2022, 172 (05) : 1379 - 1384
  • [3] Clinical Characteristics and Prognostic Factors of Testicular Sarcoma: A Population-Based Study
    Wang, Xingyuan
    Chen, Zeyu
    Qiu, Shi
    Cao, Dehong
    Jin, Kun
    Li, Jin
    Chen, Bo
    Lei, Haoran
    Huang, Yin
    Bao, Yige
    Yang, Lu
    Liu, Liangren
    Wei, Qiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hurthle cell carcinoma
    Ernaga Lorea, Ander
    Migueliz Bermejo, Iranzu
    Anda Apinaniz, Emma
    Pineda Arribas, Javier
    Toni Garcia, Marta
    Martinez de Esteban, Juan Pablo
    Insausti Serrano, Ana Maria
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (03): : 136 - 142
  • [5] Hurthle cell carcinoma of the thyroid gland: Prognostic factors and results of surgical treatment
    McDonald, MP
    Sanders, LE
    Silverman, ML
    Chan, HS
    Buyske, J
    SURGERY, 1996, 120 (06) : 1000 - 1004
  • [6] Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland - A clinicopathologic study of 50 cases
    Ghossein, RA
    Hiltzik, DH
    Carlson, DL
    Patel, S
    Shaha, A
    Shah, JP
    Tuttle, RM
    Singh, B
    CANCER, 2006, 106 (08) : 1669 - 1676
  • [7] Development and validation of a prognostic nomogram for Hurthle cell thyroid carcinoma: a SEER-based study
    Shen, Cong
    Zhao, Yunzhe
    Qiu, Xiangyuan
    Li, Peng
    Ding, Ying
    Wang, Wenlong
    Sun, Botao
    Li, Xinying
    Jiang, Wei
    GLAND SURGERY, 2022, 11 (03) : 535 - 544
  • [8] Clinical Characteristics and Prognostic Factors of 199 Salivary Acinic Cell Carcinoma
    Zhu, Lijing
    Sun, Lisha
    Li, Tie-jun
    ORAL DISEASES, 2025,
  • [9] Hurthle cell carcinoma of the thyroid gland: Prognostic factors and results of surgical treatment - Discussion
    Ditkoff, BA
    McDonald
    Heller, K
    Hay, ID
    SURGERY, 1996, 120 (06) : 1004 - 1005
  • [10] Clinical characteristics and prognostic factors of extraocular sebaceous carcinoma: a retrospective study
    Magnaterra, Elisabetta
    Venturi, Federico
    Querzoli, Giulia
    Lepri, Massimo
    Baraldi, Carlotta
    Scotti, Biagio
    Dika, Emi
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)